The Supreme Court’s decision in Actavis v Eli Lilly introduced a doctrine of equivalents and arguably also established a doctrine of prosecution history estoppel in the UK. We look at the law across Europe, and the impact the decision might have. Kingsley Egbuonu, Michael Loney and James Nurton set the scene
Philippe Campolini and Peter Blomme review the Belgian approach to equivalents and prosecution history, and discuss whether Actavis v Eli Lilly might influence future cases
In Actavis v Eli Lilly, the UK Supreme Court adjudicated on the French law on patent infringement. But, asks Celine Bey, did it do so correctly?
The doctrine of equivalents is well established in Germany. It’s good news that the UK courts are moving in the same direction, argues Philipp Widera
While the UK Supreme Court’s opinion in Actavis v Eli Lilly is a step towards a more continental approach, there remain areas of divergence. Daan de Lange and Boukje van der Maazen provide a Netherlands perspective
Spain’s courts imported the old English test into their patent law. Miquel Montañá asks: now that test has changed, will they have to change too?
Is the UK Supreme Court’s decision in Actavis v Eli Lilly a radical change to English patent law? Brian Cordery, Annsley Merelle Ward and Adrian Chew say it may not be quite as simple as that
A plan to launch a CRISPR patent pool has only attracted a few patent holders so far. Robyn Trigg and Marc Döring examine how it would work, and whether it will take off
A new bilateral agreement promises mutual recognition of certain geographical indications from Europe and China. Katharina König and Matthew Murphy explain
Erica Gould analyses a number of recent Cuban Trademark Office decisions issued in favour of US brand owners who had filed oppositions against applications made by trade mark pirates
Reforms are coming in Australia as the government responds to the Productivity Commission inquiry into IP arrangements. Karry Lai reports
The 2017 LMG Life Sciences Awards were held in New York in September
African countries have been keen to join the Madrid System, but Wayne Meiring reports that there remain problems in how it is implemented
How do US, UK and EPO tribunals compare when it comes to patent infringement disputes? Ilya Kazi contrasts tactics and procedures, drawing on lessons from recent cases
Argentina has a poor reputation for protecting IP rights. But, says Carlos Castrillo, new political winds are bringing changes
Last month Utynam attended the 31st MARQUES Annual
Conference in Prague. Here are some highlights
Federal Circuit’s Brunetti ruling: barring immoral or scandalous marks is unconstitutional restriction of free spee… https://t.co/MivCKFINHg
Federal Circuit rules in Amgen v Sandoz on remand from SCOTUS https://t.co/uYIkfVhCHG https://t.co/2OZAscsz32
RT @mdloney: Canada moves closer to joining the Hague Agreement with the release of proposed new Industrial Design Regulations https://t.co…
End of Year 2017
Tribal sovereign immunity: Taking a wrecking ball to the IPR system
The lawyer behind Allergan’s controversial transfer of patents to a Native American tribe says others are “lining up to do deals”. But, Michael Loney asks, will the PTAB rule that sovereign immunity applies in these types of deals?
The material on this site is for financial institutions, professional investors
and their professional advisers. It is for information only. Please read our
Terms and Conditions
before using the site. All material subject to strictly enforced copyright laws.
© 2017 Euromoney Institutional Investor PLC. For help please
see our FAQ.
Switching to MIP International